ClinicalTrials.Veeva

Menu

RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Renal Cell Carcinoma

Treatments

Procedure: precise segmental renal arterial clamping
Procedure: laparoscopic partial nephrectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03259477
otw-20170804-02

Details and patient eligibility

About

Renal functional reserve may be better in patients with clinical T1 renal cell carcinoma(RCC) undergoing laparoscopic partial nephrectomy with precise segmental renal artery clamping than those with complete renal arterial clamping.

Full description

Renal functional reserve (RFR) describes the capacity of the intact nephron mass to increase glomerular filtration rate(GFR) from baseline in response to stimuli (e.g., protein load).We hypothesized that renal functional reserve may be better in patients with clinical T1 renal cell carcinoma(RCC) undergoing laparoscopic partial(LPN) nephrectomy with precise segmental renal artery clamping than those with complete renal arterial clamping.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1.Age ≥18 2.Estimated GFR >30 mL/min/1.73m2 3.Anticipated intraoperative warm ischemic time ≤30 min 4.Subjects who signed informed consent forms

Exclusion criteria

  1. Allergy to iothalamate, shellfish or iodine
  2. Use of metformin or amiodarone
  3. intraoperative warm ischemic time >30 min
  4. Inability to maintain a stable regimen of medications which affect GFR for > one week prior to participation (e.g. non-steroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors, angiotensin receptor blockers)
  5. Use of medications which directly affect elimination of creatinine (e.g. cimetidine and trimethoprim)
  6. Acute exacerbation of asthma or chronic obstructive pulmonary disease within 3 months requiring hospitalization or oral steroid therapy
  7. Inadequate intravenous access
  8. Severe anemia (Hct <21%)
  9. Acute kidney injury (rise in creatinine to ≥1.5 times the previous baseline or by ≥ 0.3 mg/dL on most recent labs prior to enrollment)
  10. History of contrast-induced nephropathy
  11. Hyperthyroidism
  12. Pheochromocytoma
  13. Sickle cell disease
  14. Urinary retention or incontinence
  15. Status post organ transplant
  16. Pregnancy or active breast feeding
  17. Cognitive impairment with inability to give consent
  18. Institutionalized status

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

precise segmental clamping
Experimental group
Description:
These participants with clinical T1 renal cell carcinoma(RCC) undergo precise segmental renal arterial clamping during laparoscopic partial nephrectomy.
Treatment:
Procedure: precise segmental renal arterial clamping
Procedure: laparoscopic partial nephrectomy
complete clamping
Active Comparator group
Description:
These participants with clinical T1 renal cell carcinoma(RCC) undergo complete renal arterial clamping during laparoscopic partial nephrectomy.
Treatment:
Procedure: laparoscopic partial nephrectomy

Trial contacts and locations

1

Loading...

Central trial contact

Hao Yan; Zhenhua Shang, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems